Although the guinea pig is susceptible to varicella-zoster virus (VZV) adapted to fetal guinea pig tissue cultures, species other than the human have not proven susceptible to wild-type V N infection. Varicella-like illnesses among cercopithecoids have been associated with herpesviruses related to, but distinct from, VZV. In contrast, varicella-like illnesses occurring among the hominoids have often been associated with exposure to VZV, althcugh the etiologies have been consickred to be species-specific agents other thanVZV.
We observed a self-limited varicella-like illness in a young gorilla born and maintained in captivity in close proximity to other primates, including man. Electron microscopic examination of vesicle fluid revealed particles characteristic of an herpesvirus, an agent was isolated from vesicle fluid and nasopharyngeal secretions, and the gorilla seroconverted t o VZV. Hind Ill and EcoRl digestion of the isolate demonstrated restriction patterns identical to that of VZV.
This gorilla probably acquired varicella from a human animal handler. However, because the gorilla is phylogenetically closely related to man, it is also possible thatVZV may be a natural pathogen of other hominoids, such a s the gorilla. We studied the r o l e of the e a r l y components of complement (C') i n determining clearance of Hib by a s s e s s i n g c l e a rance of Hib i n C5 d e f i c i e n t (C5D). i n congenic C5 s u f f i c i e n t ( C 5 S ) and i n cobra-venom t r e a t e d , C ' depleted (CoV) mice. Q u a n t i t a t i v e blood c u l t u r e s were done a t 10 min, l h r , 3hr, 24hr and 48hr a f t e r i v i n o c u l a t i o n of 1-5x105 organisms. C5D cleared Hib a s w e l l a s C5S mice. However, CoV mice had impaired clearance of Hib a s ref l e c t e d l y p e r s i s t e n t high grade bacteremia.
CLEARANCE OF HAEMOPHILUS INFLUENZAE
Geometric mean Hib bacteremia (CFU/ml) CoV ( n = l l ) C5D (n=6) C5S ( Mouse s e r a contained no antibody t o Hib a s assessed by an immunofluorescence assay (IFA) and were n o t , b a c t e r i c i d a l a t concentrat i o n s up t o 50% (10xACH50). Deposition of C3 was demonstrated by IFA with C5S and C5D s e r a but not with CoV s e r a and required
Mg+t but not Caff implying a r o l e f o r t h e a l t e r n a t i v e pathway (ACP). In t h i s animal model t h a t allows d i s t i n c t i o n of the ops o n i c and l y t i c r o l e s of C ' , (1) Hib i s cleared i n t h e absence of serum b a c t e r i c i d a l a c t i v i t y and (2) C3 f i x a t i o n v i a t h e ACP i s associated with improved clearance of Hib. C ' mediated opsonizat i o n r a t h e r than l y s i s may be t h e important mechanism f o r defense a g a i n s t Hib i n t h e non-immune h o s t . LOIASIS IN AN EXPATRIATE AMERICAN CHILD:
946 DIAGNOSIS AND TREATMENT DIFFICULTIES Karen N. Olness
This i s a report of an American e x p a t r i a t e c h i l d t r e a t e d f o r l o i a s i s in the United S t a t e s . A f i v e year old g i r l was seen in
Minnesota with typical calabar swellings, associated with the loa-loa v a r i e t y of f i l a r i a s i s . Recently returned from Cameroon, she had been t r e a t e d f o r presulned f i l a r i a s i s s i x months e a r l i e r . Other than an eosinophilia of 30 per c e n t , a l l i n i ti a l laboratory f i n d i n g s were negative. These included multiple thick blood smears, u r i n a l y s i s , s t a i n i n g of urine sediment, and i n i t i a l antibody t i t e r s f o r f i l a r i a antigens. Due t o the t o x ic i t y of diethylcarbamazine, physicians were re1 uctant to t r e a t h e r unless the diagnosis could be confirmed. As a r e s u l t she underwent skin snip biopsies, r a d i o l o g i c , and ophthalmologic d i a g n o s t i c e f f o r t s ; a l l were negative. The i n t e r m i t t e n t c a l abar swellings involving her r i g h t e x t r e m i t i e s and r i g h t p e r i o rb i t a l area continued. After two months of waiting, she was t r e a t e d on the b a s i s of the c l i n i c a l diagnoses with d i e t h y l c a rbamaz i ne .
She was admitted f o r treatment, given gradually increasing dosages, and observed c a r e f u l l y f o r t o x i c i t y . She t o l e r a t e d 21 days of treatment without incident. A second a n t i f i l a r i l a n t ibody t i t e r , which had been drawn two weeks p r i o r t o treatment, was p o s i t i v e a t 1:1600. has improved outcome in human neonatal herpes, appreciable m o r t a l i t y and morbidity s t : 11 occur in t r e a t e d i n f a n t s . In 3 week old mice inoculated i n t r a n a s a l l y with herpes simplex v i r u s type 2 (HSV-2), we compared m o r t a l i t y r a t e s from treatment with a combination of two drugs vs each drug alone by using the combination index (CI) equation.
In a r e p r e s e n t a t i v e experiment, the dose of ACV beginning 48 h r a f t e r v i r a l challenge which reduced m o r t a l i t y 50% from t h a t of placebo-treated animals ( p r o t e c t i v e dose -50 o r PD-50) was 60
mg/kg/da divided twice d a i l y f o r 7 days.
The PO-50 f o r recombinant i n t e r f e r o n (rIFN) -alpha A/D ( a human hybrid a c t i v e i n mouse c e l l s ) was over 50,000 units/mouse/da. Using a high, middle, and low dose of ACV (120, 40, and 14 mg/kg/da) in combination with a high, middle and low dose of rIFN (50,000; 10,000; and 2,000 u/mouse/da), t h e PD-50 f o r ACV was reduced t o 0.02 t o 0.3 mg/kg/da with t h e high and mid IFN doses, and t h e PD-50 f o r IFN decreased t o 600 t o 5,000 u/mouse/da with a l l 3 doses of ACV. The CI value c a l c u l a t e d from these data indicated synergism. Using a s i m i l a r experimental design, t h e combination o f ara-A and ACV appeared t o be s y n e r g i s t i c with t h e mid and low doses o f t h e 2 drugs, but i n d i f f e r e n t with t h e high doses. These r e s u l t s SSPE i s a p e r s i s t e n t f a t a l measles v i r u s i n f e c t i o n of t h e cent r a l nervous system. Because r i b a v i r i n i s a c t i v e i n v i t r o a g a i n s t measles and reportedly e f f i c a c i o u s i n n a t u r a l l y occurring measles, we t r e a t e d 2 p a t i e n t s with SSPE with o r a l r i b a v i r i n . The p a t i e n t s were an 11 year old g i r l and an 18 year old boy ill f o r 2 and 8 y e a r s , r e s p e c t i v e l y . The dose was 10 mg/kg t i d f o r 3 days, then bid d a i l y f o r 6 and 14 weeks, r e s p e c t i v e l y . Serum and cerebros p i n a l f l u i d (CSF) r i b a v i r i n concentrations (courtesy of J . Connor, Univ. of C a l i f . San Diego) and measles antibody t i t e r s (Courtesy of V. Berardi, Mass. S t a t e Dept. of Health) were measured s e r i a l l y . C l i n i c a l response was evaluated by neurological examination and EEG, and t o x i c i t y was monitored by blood count, e l e c t r o l y t e s , u r i n a l y s i s , l i v e r and r e n a l function t e s t s . Ribavirin Concentration (uM) P a t i e n t #l ( ---9.4 Neurological examination and EEGs were e s s e n t i a l l y unchanged during therapy. There was no decrease i n antibody t i t e r s . Ribav i r i n was w e l l t o l e r a t e d except f o r mild hemolytic anemia i n p a t i e n t # I . CSF r i b a v i r i n l e v e l s were 75% of serum a t 7 days, and remained above 66% f o r 6 weeks. Future t h e r a p e u t i c t r i a l s should consider prolonged treatment o r higher doses of o r a l r i b a v i r i n e a r l y i n the course of SSPE.
i n d i c a t e t h a t t h e combination of two a n t i v i r a l drugs a c t i v e i n experimental HSV i n f e c t i o n s can have s y n e r g i s t i c t h e r a p e u t i c a c t i v i t y and suggest t h a t t h i s approach should be pursued in t h e treatment of human
PRP vaccination (vax) of 18 mo old children a t high r i s k f o r contracting invasive Hib d i s e a s e i s recommended by t h e ACIP. The timing of revax of such children has not been studied. Thus f a r , 30 children have been s t r a t i f i e d according t o t h e i r postvax a n t i -PRP antibody (Ab) level (determined by radioantigen binding ass a y ) following PRP vax a t 18-20 mo then s e q u e n t i a l l y assigned t o 3 groups with comparable d i s t r i b u t i o n of Ab l e v e l s t o receive revax a t 24, 30 o r 36 mo of age; each group had children who had f a i l e d t o respond t o primary vax with PRP (<30% r i s e in Ab titer!. The geometric mean t i t e r +/-t h e standard deviation, t h e % responding t o revax (>30% r i s e i n Ab t i t e r ) , and t h e % with presumed p r o t e c t i v e postvax Ab level (defined a s >1.0 pg/ml)for each vaccine group were a s follows:
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